Diagnostic and therapeutic approach to children with Nijmegen breakage syndrome in relation to development of lymphoid malignancies

Introduction and objective: Nijmegen breakage syndrome (NBS) is a rare chromosomal instability disorder. The majority of patients carry founder mutation in the NBN gene (c.657_661del5). Characteristic features of the NBS include progressive microcephaly, dysmorphic facial features, immunodeficiency,...

Full description

Saved in:
Bibliographic Details
Published in:Annals of Agricultural and Environmental Medicine 2022-06, Vol.29 (2), p.207-214
Main Authors: Filipiuk, Aleksandra, Kozakiewicz, Agata, Kośmider, Kamil, Lejman, Monika, Zawitkowska, Joanna
Format: Article
Language:English
Subjects:
Cancer
Chemotherapy
Children
Diagnosis
Genomic instability
Health risks
Hematopoietic stem cells
Immunodeficiency
Leukemia
Lymphocytes T
Lymphoma
Malignancy
Medical diagnosis
Meta-analysis
Microencephaly
Neonates
Nijmegen breakage syndrome
Patients
Pediatrics
Recombination
Risk factors
Stem cell transplantation
Stem cells
Toxicity
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction and objective: Nijmegen breakage syndrome (NBS) is a rare chromosomal instability disorder. The majority of patients carry founder mutation in the NBN gene (c.657_661del5). Characteristic features of the NBS include progressive microcephaly, dysmorphic facial features, immunodeficiency, and high predisposition to malignancy with cumulative cancer incidence by the age of 20 years, and amounted to over 70%. The aim of study is to present the latest methods of diagnosis, potential cancer risk factors and treatment of lymphoid malignancies in children with NBS. Review methods: To review the evidence using PubMed and Google Scholar search which included articles published between 2009–2021, focusing on articles published between 2013–2021. Abbreviated description of the state of knowledge: The average delay in diagnosis of NBS ranges from 4–5 years. Neonatal screening of T-cell excision circles (TRECs) and kappa-deleting recombination excision circles (KRECs) seems favourable in NBS. There are no specific protocols for the treatment of lymphoid malignancies in children with NBS, and full- dose chemotherapy is the most frequently applied method. Reducing the doses of chemotherapy does not significantly reduce the toxicity. Main cause of death is cancer progression and treatment-related mortality mostly associated with infectious complications. Patients with diagnosed cancer who received haematopoietic stem cell transplantation (HSCT) had significantly higher 20-year OS than those who did not (42.7% vs. 30.3%). Summary: Further meta-analysis is essential to establish the best monitoring and treatment regimen in patients with NBS and lymphoid malignancies.
ISSN:1232-1966
1898-2263
DOI:10.26444/aaem/143541